Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
Jessica Greenbaum is the Director of Regulatory Affairs Policy U.S. at Sandoz, where she spearheads policy initiatives to facilitate the development, review, and approval of biosimilar and generic medicines. Prior to joining Sandoz, Jessica was Counsel at a law firm, advising pharmaceutical and biotechnology companies on complex regulatory issues. Previously, Jessica served in FDA’s Office of Therapeutic Biologics and Biosimilars and the Office of the Chief Counsel, where she developed regulatory policy relating to biosimilars, interchangeables, and other biological products, including with respect to labeling, reference product exclusivity, and combination products. Jessica began her career as a Hatch-Waxman patent litigator. Jessica earned her J.D. from New York University School of Law and her Bachelor of Science from Brown University.